Literature DB >> 33584831

A Review of Genetic and Physiological Disease Mechanisms Associated With Cav1 Channels: Implications for Incomplete Congenital Stationary Night Blindness Treatment.

Tal T Sadeh1, Graeme C Black1,2, Forbes Manson1.   

Abstract

Calcium channels are crucial to a number of cellular functions. The high voltage-gated calcium channel family comprise four heteromeric channels (Cav1.1-1.4) that function in a similar manner, but that have distinct expression profiles. Three of the pore-forming α1 subunits are located on autosomes and the forth on the X chromosome, which has consequences for the type of pathogenic mutation and the disease mechanism associated with each gene. Mutations in this family of channels are associated with malignant hyperthermia (Cav1.1), various QT syndromes (Cav1.2), deafness (Cav1.3), and incomplete congenital stationary night blindness (iCSNB; Cav1.4). In this study we performed a bioinformatic analysis on reported mutations in all four Cav α1 subunits and correlated these with variant frequency in the general population, phenotype and the effect on channel conductance to produce a comprehensive composite Cav1 mutation analysis. We describe regions of mutation clustering, identify conserved residues that are mutated in multiple family members and regions likely to cause a loss- or gain-of-function in Cav1.4. Our research highlights that therapeutic treatments for each of the Cav1 channels will have to consider channel-specific mechanisms, especially for the treatment of X-linked iCSNB.
Copyright © 2021 Sadeh, Black and Manson.

Entities:  

Keywords:  CaV1.4 calcium channel; L-type calcium channels; incomplete congenital stationary night blindness; mutation analysis; treatment

Year:  2021        PMID: 33584831      PMCID: PMC7876387          DOI: 10.3389/fgene.2021.637780

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  68 in total

1.  A Reliable Targeted Next-Generation Sequencing Strategy for Diagnosis of Myopathies and Muscular Dystrophies, Especially for the Giant Titin and Nebulin Genes.

Authors:  Reda Zenagui; Delphine Lacourt; Henri Pegeot; Kevin Yauy; Raul Juntas Morales; Corine Theze; François Rivier; Claude Cances; Guilhem Sole; Dimitri Renard; Ulrike Walther-Louvier; Xavier Ferrer-Monasterio; Caroline Espil; Marie-Christine Arné-Bes; Pascal Cintas; Emmanuelle Uro-Coste; Marie-Laure Martin Negrier; Valérie Rigau; Eric Bieth; Cyril Goizet; Mireille Claustres; Michel Koenig; Mireille Cossée
Journal:  J Mol Diagn       Date:  2018-05-21       Impact factor: 5.568

2.  Putative role of Brugada syndrome genes in familial atrial fibrillation.

Authors:  P E Maltese; E Aldanova; N Kriuchkova; A Averianov; E Manara; S Paolacci; A Bruson; R Miotto; M Sartori; G Guerri; M Zuntini; G Marceddu; S Tezzele; K Tadtaeva; A Chernova; N Aksyutina; S Nikulina; S Nodari; M Bertelli
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-09       Impact factor: 3.507

3.  Genetics of intellectual disability in consanguineous families.

Authors:  Hao Hu; Kimia Kahrizi; Hans-Hilger Ropers; Hossein Najmabadi; Luciana Musante; Zohreh Fattahi; Ralf Herwig; Masoumeh Hosseini; Cornelia Oppitz; Seyedeh Sedigheh Abedini; Vanessa Suckow; Farzaneh Larti; Maryam Beheshtian; Bettina Lipkowitz; Tara Akhtarkhavari; Sepideh Mehvari; Sabine Otto; Marzieh Mohseni; Sanaz Arzhangi; Payman Jamali; Faezeh Mojahedi; Maryam Taghdiri; Elaheh Papari; Mohammad Javad Soltani Banavandi; Saeide Akbari; Seyed Hassan Tonekaboni; Hossein Dehghani; Mohammad Reza Ebrahimpour; Ingrid Bader; Behzad Davarnia; Monika Cohen; Hossein Khodaei; Beate Albrecht; Sarah Azimi; Birgit Zirn; Milad Bastami; Dagmar Wieczorek; Gholamreza Bahrami; Krystyna Keleman; Leila Nouri Vahid; Andreas Tzschach; Jutta Gärtner; Gabriele Gillessen-Kaesbach; Jamileh Rezazadeh Varaghchi; Bernd Timmermann; Fatemeh Pourfatemi; Aria Jankhah; Wei Chen; Pooneh Nikuei; Vera M Kalscheuer; Morteza Oladnabi; Thomas F Wienker
Journal:  Mol Psychiatry       Date:  2018-01-04       Impact factor: 15.992

4.  X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene.

Authors:  R Jalkanen; M Mäntyjärvi; R Tobias; J Isosomppi; E-M Sankila; T Alitalo; N T Bech-Hansen
Journal:  J Med Genet       Date:  2006-02-27       Impact factor: 6.318

5.  Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2.

Authors:  Carolyn I Hope; Dianne M Sharp; Ariana Hemara-Wahanui; Jennifer I Sissingh; Patricia Lundon; Ed A Mitchell; Marion A Maw; Gillian M Clover
Journal:  Clin Exp Ophthalmol       Date:  2005-04       Impact factor: 4.207

6.  Diagnostic exome sequencing of syndromic epilepsy patients in clinical practice.

Authors:  B Tumienė; A Maver; K Writzl; A Hodžić; G Čuturilo; R Kuzmanić-Šamija; V Čulić; B Peterlin
Journal:  Clin Genet       Date:  2018-03-23       Impact factor: 4.438

7.  A Rare Variant in CACNA1D Segregates with 7 Bipolar I Disorder Cases in a Large Pedigree.

Authors:  Jessica Ross; Erika Gedvilaite; Judith A Badner; Carolyn Erdman; Lisa Baird; Nori Matsunami; Mark Leppert; Jinchuan Xing; William Byerley
Journal:  Mol Neuropsychiatry       Date:  2016-08-03

8.  Exome Sequencing on 298 Probands With Early-Onset High Myopia: Approximately One-Fourth Show Potential Pathogenic Mutations in RetNet Genes.

Authors:  Wenmin Sun; Li Huang; Yan Xu; Xueshan Xiao; Shiqiang Li; Xiaoyun Jia; Bei Gao; Panfeng Wang; Xiangming Guo; Qingjiong Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

9.  Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H.

Authors:  J A Morrill; R H Brown; S C Cannon
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

10.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.

Authors:  Brian J O'Roak; Laura Vives; Santhosh Girirajan; Emre Karakoc; Niklas Krumm; Bradley P Coe; Roie Levy; Arthur Ko; Choli Lee; Joshua D Smith; Emily H Turner; Ian B Stanaway; Benjamin Vernot; Maika Malig; Carl Baker; Beau Reilly; Joshua M Akey; Elhanan Borenstein; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Jay Shendure; Evan E Eichler
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.